Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
5.42
+0.13 (2.46%)
At close: Jan 29, 2026, 4:00 PM EST
5.42
0.00 (0.00%)
After-hours: Jan 29, 2026, 7:07 PM EST
Alvotech Employees
Alvotech had 1,012 employees as of December 31, 2024. The number of employees increased by 13 or 1.30% compared to the previous year.
Employees
1,012
Change (1Y)
13
Growth (1Y)
1.30%
Revenue / Employee
$566,551
Profits / Employee
$68,675
Market Cap
1.70B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,700 |
| Perrigo Company | 8,379 |
| Evotec SE | 4,788 |
| Phibro Animal Health | 2,475 |
| ANI Pharmaceuticals | 897 |
| BioCryst Pharmaceuticals | 580 |
| Dynavax Technologies | 405 |
| Harrow | 382 |
ALVO News
- 7 days ago - Alvotech: Why FDA Delays Don't Break The Bull Case - Seeking Alpha
- 16 days ago - Bragar Eagel & Squire, P.C. Continues Investigations into Alvotech and Beyond Meat on Behalf of Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 22 days ago - Correction: Transactions of Managers and Closely Associated Persons - GlobeNewsWire
- 23 days ago - Transactions of Managers and Closely Associated Persons - GlobeNewsWire
- 4 weeks ago - Alvotech Secures Term Loan Facility of USD 100 Million - GlobeNewsWire
- 4 weeks ago - Changes in company's own shares - GlobeNewsWire
- 5 weeks ago - Alvotech's Financial Calendar for 2026 - GlobeNewsWire
- 5 weeks ago - Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma - GlobeNewsWire